METTL14 is a chromatin regulator independent of its RNA N 6 -methyladenosine methyltransferase activity
Protein & Cell · 2023
DOI: 10.1093/procel/pwad009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein & Cell, 2023. Verfasst von Xiaoyang Dou und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Institute for Biophysical Dynamics, University of Chicago, Chicago, IL 60637, USA. Hauptthemen laut MEDLINE: Chromatin, Histones. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, National Institutes of Health, National Natural Science Foundation of China.
Abstract (Originalsprache)
METTL3 and METTL14 are two components that form the core heterodimer of the main RNA m6A methyltransferase complex (MTC) that installs m6A. Surprisingly, depletion of METTL3 or METTL14 displayed distinct effects on stemness maintenance of mouse embryonic stem cell (mESC). While comparable global hypo-methylation in RNA m6A was observed in Mettl3 or Mettl14 knockout mESCs, respectively. Mettl14 knockout led to a globally decreased nascent RNA synthesis, whereas Mettl3 depletion resulted in transcription upregulation, suggesting that METTL14 might possess an m6A-independent role in gene regulation. We found that METTL14 colocalizes with the repressive H3K27me3 modification. Mechanistically, METTL14, but not METTL3, binds H3K27me3 and recruits KDM6B to induce H3K27me3 demethylation independent of METTL3. Depletion of METTL14 thus led to a global increase in H3K27me3 level along with a global gene suppression. The effects of METTL14 on regulation of H3K27me3 is essential for the transition from self-renewal to differentiation of mESCs. This work reveals a regulatory mechanism on heterochromatin by METTL14 in a manner distinct from METTL3 and independently of m6A, and critically impacts transcriptional regulation, stemness maintenance, and differentiation of mESCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Institute for Biophysical Dynamics, University of Chicago, Chicago, IL 60637, USA.
- Howard Hughes Medical Institute, Chicago, IL 60637, USA.
- State Key Laboratory of Protein and Plant Gene Research, Peking-Tsinghua Center for Life Sciences, School of Life Sciences, Peking University, Beijing 100871, China.
- Department of Physiology and Brain Science Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- Institute for Regenerative Medicine, Shanghai East Hospital, Shanghai Key Laboratory of Signaling and Disease Research, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji Univ…
- The Institute of Translational Medicine, School of Medicine, Zhejiang University, Hangzhou 310029, China.
ORCID-Profile: Jun Liu
Förderung
- NIEHS NIH HHS
- National Institutes of Health
- National Natural Science Foundation of China
- Beijing Nova Program
Zitieren
APA
Dou, X., Huang, L., Xiao, Y., Liu, C., Li, Y., Zhang, X., Yu, L., Zhao, R., Yang, L., Chen, C., Yu, X., Gao, B., Qi, M., Gao, Y., Shen, B., Sun, S., He, C., & Liu, J. (2023). METTL14 is a chromatin regulator independent of its RNA N 6 -methyladenosine methyltransferase activity. Protein & Cell. https://doi.org/10.1093/procel/pwad009
Vancouver
Dou X, Huang L, Xiao Y, Liu C, Li Y, Zhang X, et al. METTL14 is a chromatin regulator independent of its RNA N 6 -methyladenosine methyltransferase activity. Protein & Cell. 2023. doi:10.1093/procel/pwad009
BibTeX
@article{Dou2023,
author = {Dou, Xiaoyang and Huang, Lulu and Xiao, Yu and Liu, Chang and Li, Yini and Zhang, Xinning and Yu, Lishan and Zhao, Ran and Yang, Lei and Chen, Chuan and Yu, Xianbin and Gao, Boyang and Qi, Meijie and Gao, Yawei and Shen, Bin and Sun, Shuying and He, Chuan and Liu, Jun},
title = {METTL14 is a chromatin regulator independent of its RNA N 6 -methyladenosine methyltransferase activity},
journal = {Protein & Cell},
year = {2023},
doi = {10.1093/procel/pwad009}
}
EUVIMED